Patent ID: 9546387
Date: 2017-01-17
CPC Classifications: C12N,C12P,C12Y,Y02P

Claim:
1. A genetically engineered microorganism comprising a genetically engineered metabolic pathway for the production of muconic acid from a salicylic acid intermediate, said pathway comprising: a first module expressing a plurality of enzymes associated with the biosynthesis of salicylic acid, said plurality of enzymes comprising an isochorismate synthase (ICS) and an isochorismate pyruvate lyase (IPL); and a second module expressing a plurality of enzymes associated with the conversion of salicylic acid to muconic acid, said plurality of enzymes comprising a salicylate 1-monoxygenase (SMO) and a catechol 1,2-dioxygenase (CDO).